- Home
- MSI vs BBIO Comparison
MSI vs BBIO Comparison
Compare MSI & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSI
- BBIO
- Stock Information
- Founded
- MSI 1928
- BBIO 2015
- Country
- MSI United States
- BBIO United States
- Employees
- MSI N/A
- BBIO N/A
- Industry
- MSI Radio And Television Broadcasting And Communications Equipment
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- MSI Technology
- BBIO Health Care
- Exchange
- MSI Nasdaq
- BBIO Nasdaq
- Market Cap
- MSI 67.6B
- BBIO 6.7B
- IPO Year
- MSI N/A
- BBIO 2019
- Fundamental
- Price
- MSI $406.16
- BBIO $34.67
- Analyst Decision
- MSI Strong Buy
- BBIO Strong Buy
- Analyst Count
- MSI 9
- BBIO 12
- Target Price
- MSI $505.11
- BBIO $57.09
- AVG Volume (30 Days)
- MSI 831.6K
- BBIO 3.2M
- Earning Date
- MSI 05-01-2025
- BBIO 04-29-2025
- Dividend Yield
- MSI 1.06%
- BBIO N/A
- EPS Growth
- MSI 45.79
- BBIO N/A
- EPS
- MSI 11.91
- BBIO N/A
- Revenue
- MSI $10,956,000,000.00
- BBIO $127,415,000.00
- Revenue This Year
- MSI $6.73
- BBIO $13.67
- Revenue Next Year
- MSI $5.79
- BBIO $118.02
- P/E Ratio
- MSI $34.46
- BBIO N/A
- Revenue Growth
- MSI 7.45
- BBIO N/A
- 52 Week Low
- MSI $332.98
- BBIO $21.62
- 52 Week High
- MSI $507.82
- BBIO $39.47
- Technical
- Relative Strength Index (RSI)
- MSI 41.25
- BBIO 49.67
- Support Level
- MSI $397.00
- BBIO $33.92
- Resistance Level
- MSI $418.20
- BBIO $39.16
- Average True Range (ATR)
- MSI 8.84
- BBIO 1.43
- MACD
- MSI -1.86
- BBIO -0.16
- Stochastic Oscillator
- MSI 22.42
- BBIO 31.05
About MSI Motorola Solutions Inc.
Motorola Solutions is a leading provider of communications and analytics, primarily serving public safety departments as well as schools, hospitals, and businesses. The bulk of the firm's revenue comes from sales of land mobile radios and radio network infrastructure, but the firm also sells surveillance equipment and dispatch software. Most of Motorola's revenue comes from government agencies, while roughly 25% comes from schools and private businesses. Motorola has customers in over 100 countries and in every state in the United States.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.